Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eilean Therapeutics is a small molecule oncology drug discovery company that is committed to improving the lives of cancer patients by defeating cancer. Many cancers develop resistance to treatment either by developing mutations or escape mechanisms, thereby limiting the activity of current therapeutics. By developing pan-variant therapies that target the major drivers of cancer resistance, we are overcoming the limitations o...
    Eilean Therapeutics is a small molecule oncology drug discovery company that is committed to improving the lives of cancer patients by defeating cancer. Many cancers develop resistance to treatment either by developing mutations or escape mechanisms, thereby limiting the activity of current therapeutics. By developing pan-variant therapies that target the major drivers of cancer resistance, we are overcoming the limitations of current oncology therapeutics and developing best-in-class therapeutics for hematologic malignancies.

    List your booth number for exhibitions, ask us